Epigenetic regulation in cystogenesis

Advances in Experimental Medicine and Biology

Volumn 933, Issue , 2016, Pages 59-68

  Woo, Yu Mi ^a  

^a Sookmyung Women's University   (South Korea)

Author keywords

Cyst; Epigenetic regulation; PKD

Indexed keywords

BIOLOGICAL MARKER; DNA METHYLTRANSFERASE INHIBITOR; HISTONE DEACETYLASE INHIBITOR; MICRORNA; GENETIC MARKER;

BIOGENESIS; CHROMATIN STRUCTURE; CYST; CYSTOGENESIS; DNA METHYLATION; DRUG EFFECT; EPIGENETICS; GENE EXPRESSION; GENETIC REGULATION; HISTONE MODIFICATION; HUMAN; KIDNEY POLYCYSTIC DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; ANIMAL; CHROMOSOME; DRUG EFFECTS; GENETIC EPIGENESIS; GENETIC MARKER; GENETICS; MOLECULARLY TARGETED THERAPY; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT;

ANIMALS; CHROMOSOMES; EPIGENESIS, GENETIC; GENETIC MARKERS; HUMANS; MOLECULAR TARGETED THERAPY; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT;

EID: 84991694145     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-981-10-2041-4_6     Document Type: Chapter

References (60)

1. Aran D, Toperoff G, Rosenberg M, Hellman A (2011) Replication timing-related and gene bodyspecifi c methylation of active human genes. Hum Mol Genet 20(4):670-680. doi: 10.1093/hmg/ddq513
2. Ben-Dov IZ, Tan YC, Morozov P, Wilson PD, Rennert H, Blumenfeld JD, Tuschl T (2014) Urine microRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: description of miRNA profi les at baseline. PLoS One 9(1):e86856. doi: 10.1371/journal.pone.0086856
3. Bestor TH (2000) The DNA methyltransferases of mammals. Hum Mol Genet 9(16):2395-2402
4. Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16(1):6-21. doi: 10.1101/gad.947102
5. Cao Y, Semanchik N, Lee SH, Somlo S, Barbano PE, Coifman R, Sun Z (2009) Chemical modifi er screen identifi es HDAC inhibitors as suppressors of PKD models. Proc Natl Acad Sci U S A 106(51):21819-21824. doi: 10.1073/pnas.0911987106
6. Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC, Schuller DE, Yu L, Bloomfi eld CD, Caligiuri MA, Yates A, Nishikawa R, Su Huang H, Petrelli NJ, Zhang X, O’Dorisio MS, Held WA, Cavenee WK, Plass C (2000) Aberrant CpG-island methylation has non-random and tumour-type-specifi c patterns. Nat Genet 24(2):132-138. doi: 10.1038/72785
7. Deaton AM, Webb S, Kerr AR, Illingworth RS, Guy J, Andrews R, Bird A (2011) Cell typespecifi c DNA methylation at intragenic CpG islands in the immune system. Genome Res 21(7):1074-1086. doi: 10.1101/gr.118703.110
8. Deribe YL, Wild P, Chandrashaker A, Curak J, Schmidt MH, Kalaidzidis Y, Milutinovic N, Kratchmarova I, Buerkle L, Fetchko MJ, Schmidt P, Kittanakom S, Brown KR, Jurisica I, Blagoev B, Zerial M, Stagljar I, Dikic I (2009) Regulation of epidermal growth factor receptor traffi cking by lysine deacetylase HDAC6. Sci Signal 2(102):ra84. doi: 10.1126/scisignal.2000576
9. Dweep H, Sticht C, Kharkar A, Pandey P, Gretz N (2013) Parallel analysis of mRNA and microRNA microarray profi les to explore functional regulatory patterns in polycystic kidney disease: using PKD/Mhm rat model. PLoS One 8(1):e53780. doi: 10.1371/journal.pone.0053780
10. Esau CC, Monia BP (2007) Therapeutic potential for microRNAs. Adv Drug Deliv Rev 59(2-3):101-114. doi: 10.1016/j.addr.2007.03.007
11. Esteller M (2005) Aberrant DNA methylation as a cancer-inducing mechanism. Annu Rev Pharmacol Toxicol 45:629-656. doi: 10.1146/annurev.pharmtox.45.120403.095832
12. Fan LX, Li X, Magenheimer B, Calvet JP (2012) Inhibition of histone deacetylases targets the transcription regulator Id2 to attenuate cystic epithelial cell proliferation. Kidney Int 81(1):76-85. doi: 10.1038/ki.2011.296
13. Felsenfeld G, Groudine M (2003) Controlling the double helix. Nature 421(6921):448-453. doi: 10.1038/nature01411
14. Gius D, Cui H, Bradbury CM, Cook J, Smart DK, Zhao S, Young L, Brandenburg SA, Hu Y, Bisht KS, Ho AS, Mattson D, Sun L, Munson PJ, Chuang EY, Mitchell JB, Feinberg AP (2004) Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. Cancer Cell 6(4):361-371. doi: 10.1016/j.ccr.2004.08.029
15. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP (2007) MicroRNA targeting specifi city in mammals: determinants beyond seed pairing. Mol Cell 27(1):91-105. doi: 10.1016/j.molcel.2007.06.017
16. Gupta S, Kim SY, Artis S, Molfese DL, Schumacher A, Sweatt JD, Paylor RE, Lubin FD (2010) Histone methylation regulates memory formation. J Neurosci Off J Soc Neurosci 30(10):3589-3599. doi: 10.1523/JNEUROSCI.3732-09.2010
17. Herman JG, Baylin SB (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349(21):2042-2054. doi: 10.1056/NEJMra023075
18. Hu HY, Yan Z, Xu Y, Hu H, Menzel C, Zhou YH, Chen W, Khaitovich P (2009) Sequence features associated with microRNA strand selection in humans and fl ies. BMC Genomics 10:413. doi: 10.1186/1471-2164-10-413
19. Illingworth R, Kerr A, Desousa D, Jorgensen H, Ellis P, Stalker J, Jackson D, Clee C, Plumb R, Rogers J, Humphray S, Cox T, Langford C, Bird A (2008) A novel CpG island set identifi es tissue-specifi c methylation at developmental gene loci. PLoS Biol 6(1):e22. doi: 10.1371/journal.pbio.0060022
20. Juttermann R, Li E, Jaenisch R (1994) Toxicity of 5-aza-2′-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc Natl Acad Sci U S A 91(25):11797-11801
21. Kim VN, Han J, Siomi MC (2009) Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10(2):126-139. doi: 10.1038/nrm2632
22. Kouzarides T (2007) Chromatin modifi cations and their function. Cell 128(4):693-705. doi: 10.1016/j.cell.2007.02.005
23. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M (2005) Silencing of microRNAs in vivo with ‘antagomirs’. Nature 438(7068):685-689. doi: 10.1038/nature04303
24. Laird PW, Jackson-Grusby L, Fazeli A, Dickinson SL, Jung WE, Li E, Weinberg RA, Jaenisch R (1995) Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81(2):197-205
25. Lakhia R, Hajarnis S, Williams D, Aboudehen K, Yheskel M, Xing C, Hatley ME, Torres VE, Wallace DP, Patel V (2015) MicroRNA-21 aggravates cyst growth in a model of polycystic kidney disease. J Am Soc Nephrol JASN. doi: 10.1681/ASN.2015060634
26. Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5):843-854
27. Lee SO, Masyuk T, Splinter P, Banales JM, Masyuk A, Stroope A, Larusso N (2008) MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease. J Clin Invest 118(11):3714-3724. doi: 10.1172/JCI34922
28. Li X (2011) Epigenetics and autosomal dominant polycystic kidney disease. Biochim Biophys Acta 1812(10):1213-1218. doi: 10.1016/j.bbadis.2010.10.008
29. Lindow M, Gorodkin J (2007) Principles and limitations of computational microRNA gene and target fi nding. DNA Cell Biol 26(5):339-351. doi: 10.1089/dna.2006.0551
30. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM, Edsall L, Antosiewicz-Bourget J, Stewart R, Ruotti V, Millar AH, Thomson JA, Ren B, Ecker JR (2009) Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462(7271):315-322. doi: 10.1038/nature08514
31. Liu W, Fan LX, Zhou X, Sweeney WE Jr, Avner ED, Li X (2012) HDAC6 regulates epidermal growth factor receptor (EGFR) endocytic traffi cking and degradation in renal epithelial cells. PLoS One 7(11):e49418. doi: 10.1371/journal.pone.0049418
32. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O’Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105(30):10513-10518. doi: 10.1073/pnas.0804549105
33. Nahhas F, Dryden SC, Abrams J, Tainsky MA (2007) Mutations in SIRT2 deacetylase which regulate enzymatic activity but not its interaction with HDAC6 and tubulin. Mol Cell Biochem 303(1-2):221-230. doi: 10.1007/s11010-007-9478-6
34. North BJ, Marshall BL, Borra MT, Denu JM, Verdin E (2003) The human Sir2 ortholog, SIRT2, is an NAD + -dependent tubulin deacetylase. Mol Cell 11(2):437-444
35. Noureddine L, Hajarnis S, Patel V (2013) MicroRNAs and polycystic kidney disease. Drug Discov Today Dis Mod 10(3):e137-e1743. doi: 10.1016/j.ddmod.2013.10.001
36. Okano M, Bell DW, Haber DA, Li E (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99(3):247-257
37. Pandey P, Brors B, Srivastava PK, Bott A, Boehn SN, Groene HJ, Gretz N (2008) Microarraybased approach identifi es microRNAs and their target functional patterns in polycystic kidney disease. BMC Genomics 9:624. doi: 10.1186/1471-2164-9-624
38. Pandey P, Qin S, Ho J, Zhou J, Kreidberg JA (2011) Systems biology approach to identify transcriptomereprogramming and candidate microRNA targets during the progression of polycystic kidney disease. BMC Syst Biol 5:56. doi: 10.1186/1752-0509-5-56
39. Pastorelli LM, Wells S, Fray M, Smith A, Hough T, Harfe BD, McManus MT, Smith L, Woolf AS, Cheeseman M, Greenfi eld A (2009) Genetic analyses reveal a requirement for Dicer1 in the mouse urogenital tract. Mamm Genome Off J Int Mamm Genome Soc 20(3):140-151. doi: 10.1007/s00335-008-9169-y
40. Patel V, Noureddine L (2012) MicroRNAs and fi brosis. Curr Opin Nephrol Hypertens 21(4):410-416. doi: 10.1097/MNH.0b013e328354e559
41. Patel V, Hajarnis S, Williams D, Hunter R, Huynh D, Igarashi P (2012) MicroRNAs regulate renal tubule maturation through modulation of Pkd1. J Am Soc Nephrol JASN 23(12):1941-1948. doi: 10.1681/ASN.2012030321
42. Patel V, Williams D, Hajarnis S, Hunter R, Pontoglio M, Somlo S, Igarashi P (2013) miR-17-92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease. Proc Natl Acad Sci U S A 110(26):10765-10770. doi: 10.1073/pnas.1301693110
43. Sawan C, Herceg Z (2010) Histone modifi cations and cancer. Adv Genet 70:57-85. doi: 10.1016/B978-0-12-380866-0.60003-4
44. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455(7209):58-63. doi: 10.1038/nature07228
45. Taby R, Issa JP (2010) Cancer epigenetics. CA Cancer J Clin 60(6):376-392. doi: 10.3322/caac.20085
46. Tran U, Zakin L, Schweickert A, Agrawal R, Doger R, Blum M, De Robertis EM, Wessely O (2010) The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity. Development 137(7):1107-1116. doi: 10.1242/dev.046045
47. Van Bodegom D, Saifudeen Z, Dipp S, Puri S, Magenheimer BS, Calvet JP, El-Dahr SS (2006) The polycystic kidney disease-1 gene is a target for p53-mediated transcriptional repression. J Biol Chem 281(42):31234-31244. doi: 10.1074/jbc.M606510200
48. van Bodegom D, Roessingh W, Pridjian A, El Dahr SS (2010) Mechanisms of p53-mediated repression of the human polycystic kidney disease-1 promoter. Biochim Biophys Acta 1799(7):502-509. doi: 10.1016/j.bbagrm.2010.04.001
49. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, Galas DJ, Wang K (2010) The microRNA spectrum in 12 body fl uids. Clin Chem 56(11):1733-1741. doi: 10.1373/clinchem.2010.147405
50. Woo YM, Bae JB, Oh YH, Lee YG, Lee MJ, Park EY, Choi JK, Lee S, Shin Y, Lyu J, Jung HY, Lee YS, Hwang YH, Kim YJ, Park JH (2014) Genome-wide methylation profi ling of ADPKD identifi ed epigenetically regulated genes associated with renal cyst development. Hum Genet 133(3):281-297. doi: 10.1007/s00439-013-1378-0
51. Woo YM, Shin Y, Hwang JA, Hwang YH, Lee S, Park EY, Kong HK, Park HC, Lee YS, Park JH (2015) Epigenetic silencing of the MUPCDH gene as a possible prognostic biomarker for cystgrowth in ADPKD. Sci Rep 5:15238. doi: 10.1038/srep15238
52. Xia S, Li X, Johnson T, Seidel C, Wallace DP, Li R (2010) Polycystin-dependent fl uid fl ow sensing targets histone deacetylase 5 to prevent the development of renal cysts. Development 137(7):1075-1084. doi: 10.1242/dev.049437
53. Yang JS, Lai EC (2011) Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants. Mol Cell 43(6):892-903. doi: 10.1016/j.molcel.2011.07.024
54. Yoo CB, Jones PA (2006) Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov 5(1):37-50. doi: 10.1038/nrd1930
55. Zen K, Zhang CY (2012) Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev 32(2):326-348. doi: 10.1002/med.20215
56. Zhang Y, Reinberg D (2001) Transcription regulation by histone methylation: interplay between different covalent modifi cations of the core histone tails. Genes Dev 15(18):2343-2360. doi: 10.1101/gad.927301
57. Zhou VW, Goren A, Bernstein BE (2011) Charting histone modifi cations and the functional organization of mammalian genomes. Nat Rev Genet 12(1):7-18. doi: 10.1038/nrg2905
58. Zhou X, Fan LX, Sweeney WE Jr, Denu JM, Avner ED, Li X (2013) Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease. J Clin Invest 123(7):3084-3098.doi: 10.1172/JCI64401
59. Zhou X, Fan LX, Li K, Ramchandran R, Calvet JP, Li X (2014) SIRT2 regulates ciliogenesis and contributes to abnormal centrosome amplifi cation caused by loss of polycystin-1. Hum Mol Genet 23(6):1644-1655. doi: 10.1093/hmg/ddt556
60. Zhou X, Fan LX, Peters DJ, Trudel M, Bradner JE, Li X (2015) Therapeutic targeting of BET bromodomain protein, Brd4, delays cyst growth in ADPKD. Hum Mol Genet 24(14):3982-3993. doi: 10.1093/hmg/ddv136